Clinical Trial Update: REsPonse to Interferon-Alpha in InterfeRon-β Neutralizing Antibody Positive Multiple Sclerosis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating interferon-alpha in multiple sclerosis patients with neutralizing antibodies to interferon-beta; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Interferon-alpha (interferon alpha)

Snippet

Sponsor: Melinda Magyari | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED